BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Digital Artificial Intelligence

Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins

Fujitsu Limited and the HPC- and AI-driven Drug Development Platform Division of the RIKEN Center for Computational Science today announced that they have ...

October 11, 2023 | News

Wolters Kluwer unveils generative AI Labs for UpToDate

UpToDate is used by more than two million users at over 44,000 healthcare organizations in over 190 countries. Medical professionals turn to UpToDate to vi...

October 04, 2023 | News

Seven AI/ML Life Sciences Innovators in Clarivate's Watchlist

United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery C...

September 28, 2023 | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...

September 25, 2023 | News

Kai Health’s Embryo Assessment AI Achieves European Medical Device Certification

Kai Health's innovative solution utilizes artificial intelligence to objectively analyze embryo images, providing predictions of embryo viability. This bre...

September 22, 2023 | News

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform ca...

September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized a...

September 20, 2023 | News

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...

September 15, 2023 | News

Fujitsu and Baptist Health South Florida Revolutionize OR Scheduling for Better Utilization and Finances

Recent trials with the solution delivered 37% improvement in available prime-time minutes over a three-month period Fujitsu announced the launch of an inn...

September 15, 2023 | News

Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...

September 12, 2023 | News

Paige Partners with Microsoft to Create World's Largest Cancer-Fighting AI Model

Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images ...

September 08, 2023 | News

SOAP Health and AESOP Technology Join Forces for Advanced AI Clinical Decision-Support and Coding

SOAP Health and AESOP Technology are excited to announce a transformative partnership that will push the boundaries of AI-enhanced med...

September 08, 2023 | News

IBT and ATLATL Join Forces to Tackle Challenges in Brain Health

Starting out of China, IBT Global is a rising player in Digital Therapeutics (DTx) with an experienced cross-functional team operating at the intersection ...

September 05, 2023 | News

BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...

August 25, 2023 | News

Stay Connected